Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Obesity drug developer BioAge Labs (BIOA) files for U.S. IPO to offer 7.5M shares at $17-$19 implying valution of up to $602M ...

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, is seeking ...

Heading into fall and winter virus season, and with a new COVID variant raising questions, Americans will soon be able to get free test kits mailed to their homes.

BioAge Labs Inc., a clinical-stage biotechnology company developing therapies for obesity and metabolic disease, has filed for an initial public offering. The company said Tuesday in a filing with ...

BioAge Labs has appointed former GSK CEO Jean-Pierre Garnier as chair of its board of directors, bringing the pharma veteran back into the anti-aging space 16 years after he made a big bet on the ...

RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc. (“BioAge”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the ...

Sept 3 (Reuters) - BioAge Labs, an obesity therapy-focused startup that has also collaborated with Eli Lilly (LLY.N), opens new tab, filed for an initial public offering in the United States on ...

(Reuters) -BioAge Labs, an obesity therapy-focused startup that has also collaborated with Eli Lilly, filed for an initial public offering in the United States on Tuesday as it looks to capitalize ...

An at-home testosterone test kit is a convenient way to check your testosterone levels and can be a helpful first step in deciding if you’d like to meet with a healthcare professional to confirm ...